SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-073825
Filing Date
2023-12-29
Accepted
2023-12-29 16:00:09
Documents
16
Period of Report
2023-12-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybx-20231229.htm   iXBRL 8-K 46662
2 EX-10.1 sybx-ex10_1.htm EX-10.1 39514
3 EX-10.2 sybx-ex10_2.htm EX-10.2 39696
4 GRAPHIC img138293864_0.jpg GRAPHIC 17284
5 GRAPHIC img139217385_0.jpg GRAPHIC 17284
  Complete submission text file 0000950170-23-073825.txt   320970

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sybx-20231229_lab.xml EX-101.LAB 19247
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sybx-20231229.xsd EX-101.SCH 2480
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sybx-20231229_pre.xml EX-101.PRE 12004
10 EXTRACTED XBRL INSTANCE DOCUMENT sybx-20231229_htm.xml XML 4872
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 231527568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)